Spain's Grifols says Q1 net profit up 19 pct y/y
MADRID May 2 (Reuters) - Spanish pharmaceutical company Grifols said on Thursday net profit rose 19 percent in the first quarter of 2013 from a year earlier to 115.7 million euros ($152.6 million), boosted by overseas sales, especially Latin America and Asia.
Including the one-time costs from the acquisition of U.S. company Talecris last June, the world's third-largest blood products maker said net profit rose 34.8 percent to 91 million euros.
Barcelona-based Grifols, which generates over 90 percent of its sales outside its recession-hit home market, said first quarter revenue increased 2.6 percent to 683.7 million euros. ($1 = 0.7580 euros) (Reporting By Paul Day; Editing by Carlos Ruano)
- Judge rejects strict limits on U.S. nurse who treated Ebola patients |
- Test flight of Virgin Galactic spaceship ends in fatal crash in California
- Suspect in Pennsylvania police ambush denied bail |
- Dow, S&P 500 end at record highs; BoJ move adds fuel to rally |
- Judge issues order enforcing Ebola isolation of defiant Maine nurse